NO303447B1 - AnalogifremgangsmÕte for fremstilling av et terapeutisk aktivt hydrokloridsalt eller etandisulfonatsalt av 5-(2-klor-1-hydroksyetyl)-4-metyltiazol - Google Patents

AnalogifremgangsmÕte for fremstilling av et terapeutisk aktivt hydrokloridsalt eller etandisulfonatsalt av 5-(2-klor-1-hydroksyetyl)-4-metyltiazol

Info

Publication number
NO303447B1
NO303447B1 NO930452A NO930452A NO303447B1 NO 303447 B1 NO303447 B1 NO 303447B1 NO 930452 A NO930452 A NO 930452A NO 930452 A NO930452 A NO 930452A NO 303447 B1 NO303447 B1 NO 303447B1
Authority
NO
Norway
Prior art keywords
salt
methylthiazole
hydroxyethyl
chloro
preparation
Prior art date
Application number
NO930452A
Other languages
English (en)
Norwegian (no)
Other versions
NO930452L (no
NO930452D0 (no
Inventor
Bernard Robin Boar
Alan John Cross
Alfred Richard Green
Curt-Eric Hagberg
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO930452L publication Critical patent/NO930452L/no
Publication of NO930452D0 publication Critical patent/NO930452D0/no
Publication of NO303447B1 publication Critical patent/NO303447B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO930452A 1990-08-15 1993-02-09 AnalogifremgangsmÕte for fremstilling av et terapeutisk aktivt hydrokloridsalt eller etandisulfonatsalt av 5-(2-klor-1-hydroksyetyl)-4-metyltiazol NO303447B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9002659A SE9002659D0 (sv) 1990-08-15 1990-08-15 New pharmaceutical formulations
PCT/SE1991/000522 WO1992003134A1 (en) 1990-08-15 1991-08-07 New pharmaceutical formulations of 5-(2-chloro-1-hydroxyethyl)-4-methylthiazole

Publications (3)

Publication Number Publication Date
NO930452L NO930452L (no) 1993-02-09
NO930452D0 NO930452D0 (no) 1993-02-09
NO303447B1 true NO303447B1 (no) 1998-07-13

Family

ID=20380161

Family Applications (1)

Application Number Title Priority Date Filing Date
NO930452A NO303447B1 (no) 1990-08-15 1993-02-09 AnalogifremgangsmÕte for fremstilling av et terapeutisk aktivt hydrokloridsalt eller etandisulfonatsalt av 5-(2-klor-1-hydroksyetyl)-4-metyltiazol

Country Status (26)

Country Link
US (1) US5385921A (lt)
EP (1) EP0619734B1 (lt)
JP (1) JP3094077B2 (lt)
AT (1) ATE164066T1 (lt)
AU (1) AU657490B2 (lt)
BG (1) BG97446A (lt)
CA (1) CA2088775A1 (lt)
CZ (1) CZ279586B6 (lt)
DE (1) DE69129126T2 (lt)
DK (1) DK0619734T3 (lt)
ES (1) ES2114891T3 (lt)
FI (1) FI930608A0 (lt)
HU (1) HUT65821A (lt)
IE (1) IE912818A1 (lt)
IL (1) IL99169A (lt)
IS (1) IS3743A7 (lt)
LT (1) LT3978B (lt)
LV (1) LV10921B (lt)
NO (1) NO303447B1 (lt)
NZ (1) NZ239329A (lt)
PT (1) PT98688B (lt)
RO (1) RO112994B1 (lt)
RU (1) RU2093155C1 (lt)
SE (1) SE9002659D0 (lt)
SK (1) SK8793A3 (lt)
WO (1) WO1992003134A1 (lt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9901658D0 (sv) * 1999-05-06 1999-05-06 Astra Ab New formulation
SE9904177D0 (sv) * 1999-11-18 1999-11-18 Astra Ab Novel compounds
WO2002083863A2 (en) 2001-04-17 2002-10-24 Sepracor, Inc. Thiazole and other heterocyclic ligands and use thereof
CN103772313B (zh) * 2014-01-02 2015-10-14 郑桂富 一种4-甲基-5-(2-羟乙基)噻唑的合成方法
CN112262814A (zh) * 2020-10-26 2021-01-26 宜宾学院 油樟叶渣发酵床养鸡方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2825966A1 (de) * 1978-06-14 1980-01-03 Basf Ag Saures galvanisches nickelbad, das sulfobetaine als glanz- und einebnungsmittel enthaelt
GB8600783D0 (en) * 1986-01-14 1986-02-19 Merck Sharp & Dohme N-methyl-d-aspartate receptor antagonists

Also Published As

Publication number Publication date
HUT65821A (en) 1994-07-28
EP0619734B1 (en) 1998-03-18
US5385921A (en) 1995-01-31
CZ16693A3 (en) 1994-02-16
FI930608A (fi) 1993-02-11
WO1992003134A1 (en) 1992-03-05
IL99169A (en) 1995-10-31
NO930452L (no) 1993-02-09
IE912818A1 (en) 1992-02-26
IS3743A7 (is) 1992-02-16
CZ279586B6 (cs) 1995-05-17
SE9002659D0 (sv) 1990-08-15
SK8793A3 (en) 1993-07-07
LT3978B (en) 1996-06-25
PT98688A (pt) 1992-07-31
AU8409291A (en) 1992-03-17
LTIP1714A (en) 1995-09-25
JP3094077B2 (ja) 2000-10-03
DE69129126D1 (de) 1998-04-23
NO930452D0 (no) 1993-02-09
FI930608A0 (fi) 1993-02-11
AU657490B2 (en) 1995-03-16
NZ239329A (en) 1994-11-25
ES2114891T3 (es) 1998-06-16
LV10921B (en) 1996-08-20
DE69129126T2 (de) 1998-07-23
RO112994B1 (ro) 1998-03-30
JPH06500097A (ja) 1994-01-06
PT98688B (pt) 1999-01-29
EP0619734A1 (en) 1994-10-19
CA2088775A1 (en) 1992-02-16
ATE164066T1 (de) 1998-04-15
HU9300388D0 (en) 1993-04-28
RU2093155C1 (ru) 1997-10-20
DK0619734T3 (da) 1998-10-05
IL99169A0 (en) 1992-07-15
LV10921A (lv) 1995-12-20
BG97446A (en) 1994-03-24

Similar Documents

Publication Publication Date Title
FI96861C (fi) Menetelmä terapeuttisesti aktiivisten substituoitujen indolyylipyrrolijohdannaisten valmistamiseksi
NO179283C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte azoler
FI963424A0 (fi) Menetelmä terapeuttisesti aktiivisten tiofeenisulfonamidien valmistamiseksi
NO171853C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 7beta-(2-(tiazol-4-yl)-2-alkoksyiminoacetamido)-3-((1-pyrazolio)metyl)-3-cefem-4-karboksylat-forbindelser
NO179448C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive forbindelser
NO176319C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive furanderivater
FI930723A0 (fi) Menetelmä terapeuttisesti aktiivisten tiatsolidiinijohdannaisten valmistamiseksi
NO178068C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive tiazolidindionderivater
NO903941D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive diazepinon-derivater.
NO178543C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive benzopyranderivater
NO175528C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive fenylacetamid-derivater
NO178338C (no) Analogifremgangsmåte for fremstilling av en terapeutisk aktiv benzimidazolforbindelse samt mellomprodukt
NO175976C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 4-(1,6-dihydro-6-okso-pyridazinyl-3-oksy)-3-kromanolderivater
NO178336C (no) Analogifremgangsmåte for fremstilling av en terapeutisk aktiv benzimidazolforbindelse og mellomprodukter
NO303447B1 (no) AnalogifremgangsmÕte for fremstilling av et terapeutisk aktivt hydrokloridsalt eller etandisulfonatsalt av 5-(2-klor-1-hydroksyetyl)-4-metyltiazol
NO167734C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte aminderivater.
NO178698C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive glycerolderivater
NO173607C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive tienotriazolo-diazepin-derivater
FI903077A0 (fi) Menetelmä valmistaa terapeuttisesti aktiivisia R(-)-3-kinuklidinolijohdannaisia
NO173606C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tieno- triazolo-diazepin-derivater
ZA911452B (en) New use of 5-(2-(tert-butylamino)-1-hydroxyethyl)-m-phenylene-bis(dimethylcarbanate)
NO177710C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive slektede analoger
FI89595B (fi) Foerfarande foer framstaellning av terapeutiskt aktiva 2-(tioalkylamino)etyl-1H-imidazolderivat
FI97885C (fi) Menetelmä terapeuttisesti aktiivisten nojirimysiinijohdannaisten valmistamiseksi
NO173504C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tieno-triazolo-diazepin-derivater

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN FEBRUARY 2002